Real-time oncology signals your team can act on before the window closes
The same signal layer, EMR data, lab results, treatment and progression indicators, can trigger a trial enrollment, a physician outreach, or a care-gap intervention, routed through a human in the loop.
How OncoLens helps
Our differentiation lies in our close collaborations with our centers, and our ability to engage HCPs directly
Biomarker results from every source
- Not just what shows up in one system
- OncoLens captures results from in-house labs and NGS vendors alike
- Results are read as they are generated, inside the clinical workflow
Indicators that flag exactly when to engage
- Treatment-based and progression-based indicators
- They mark the moment a patient approaches a treatment decision
- They fire even when biomarker testing is not the entry point
Personalized alerts, with a human in the loop
- OncoLens turns signal into action, once a person has confirmed it
- A physician outreach
- A tumor board discussion
- Targeted HCP education
Frequently asked questions
What counts as a “signal” in OncoLens’s signal-based action?
A biomarker result captured from an in-house lab or an NGS vendor, or a treatment- or progression-based indicator drawn from EMR data. Any real-time clinical event that suggests it is time to act, whether that action is research, commercial, or care-team engagement.
How fast can a signal turn into action?
Because signals are captured directly from EMR and lab data as they occur, alerts route through a human-in-the-loop service almost immediately, rather than waiting for claims data or a periodic data refresh to catch up.
Does a human review every alert before it’s acted on?
Yes. Every signal is routed through a human-in-the-loop layer, so a physician outreach, patient pre-screen, or care-gap intervention only happens after a person has confirmed it makes sense.
What kinds of action can a signal trigger?
The same signal layer can support very different next steps depending on the use case: a research team enrolling a patient in a trial, a commercial team engaging a physician, or a care team closing a care gap.
Do signals only come from biomarker testing?
No. Signals include treatment- and progression-based indicators as well as biomarker results, so action can be triggered even when biomarker testing is not the entry point.
Put your signals to work
Share which clinical events matter to your team. OncoLens will show you what it can see, how fast it surfaces, and what happens next.